How do organisations implement IEC 81001-5-1?

How IEC 81001-5-1 Gets Implemented Across the Product Lifecycle

IEC 81001-5-1 is implemented by making security engineering part of the health software lifecycle, not a late-stage review. That means defining security requirements early, carrying them into design and development, and then maintaining them through release, support, and update management so the product remains secure in real operating conditions.

The practical shift is from “document the control” to “prove the control works in the product.” Teams need to show that threat modelling informs design decisions, that security testing is repeated as the software changes, and that post-release obligations are owned rather than left ambiguous between the supplier, integrator, and operator.

For medical device programmes, the operational baseline is usually broader than secure coding alone. The Medical Device Security Guide is the natural companion for organisations that need to connect IEC 81001-5-1 to premarket cybersecurity, postmarket support, SBOM use, and clinical downtime planning.

What Organisations Must Put in Place to Make the Standard Real

Implementation usually succeeds when security responsibilities are built into the product governance model. Someone must own disclosure handling, patch triage, configuration guidance, vulnerability response, and the evidence trail that proves these responsibilities are being met. Without that ownership, the standard becomes a set of statements with no durable operating model behind them.

The other essential element is traceability. Requirements should be linked to design artefacts, verification results, known limitations, and maintenance commitments so that assurance reviews can follow the chain from intent to evidence. That traceability is what makes the standard useful in procurement, supplier evaluation, and regulated assurance discussions.

Because the standard is a control framework in practice as much as a development discipline, a general implementation baseline can help teams structure the work. ISO/IEC 27002:2022 Information Security Controls is useful where organisations want a broader control catalogue to organise policy, process, and technical safeguards around the product programme.

How to Prove Compliance Through Testing, Maintenance, and Supplier Evidence

Testing should not stop at code review or a single pre-release penetration test. Organisations need a repeatable process for vulnerability discovery, verification, remediation, and regression testing, because the security posture of health software changes as dependencies, configurations, and threat conditions change. Maintenance planning is therefore part of implementation, not an afterthought.

Supplier evidence matters because buyers increasingly need assurance that the software can be patched, supported, and configured safely over its life. That evidence normally includes vulnerability disclosure procedures, update mechanisms, supported deployment assumptions, and the limits of the supplier’s support obligations. If the supplier cannot explain those items clearly, the organisation has an assurance gap even if the software appears secure on day one.

For teams that want a control-oriented implementation pattern, the ISO/IEC 27002:2022 Information Security Controls guidance is also useful for turning requirements into operational controls, while the OWASP Cheat Sheet Series offers practical engineering patterns for secure implementation work such as authentication, secrets handling, and input validation.

Risk and Threat Considerations

Health software that is implemented without a maintenance and disclosure model can create patient safety risk as well as security risk. The main exposure is not only initial compromise, but also the failure to patch, configure, or retire software safely after deployment, especially where the product supports clinical workflows or depends on third-party components.

Failure mechanism: Security requirements are defined too late, testing is treated as a one-time gate, and supplier responsibility for vulnerability handling or configuration guidance remains unclear. That leaves exploitable weaknesses in production and makes assurance claims hard to defend.

Impact: Vulnerabilities can persist into live clinical environments, updates may be delayed or misapplied, and procurement teams may lack the evidence needed to judge residual risk. In the worst case, the result is unsafe downtime, unreliable software support, or preventable exposure of sensitive health systems.

Practitioner Guidance

What to prioritise: Treat maintenance obligations as part of the implementation scope from the start. The first question is not whether the product has security features, but whether the organisation can support disclosure, patching, and configuration decisions throughout the software’s life.

What to verify: Confirm that security requirements are traceable to design and test evidence, that vulnerability handling has an owner, and that support commitments are written in a way procurement can enforce. If any of those elements is missing, the implementation is incomplete even if development practices look mature.

Practitioner takeaway: IEC 81001-5-1 is implemented successfully when security is run as a product lifecycle capability, with evidence, ownership, and maintenance obligations that survive release.

Related resources from NHI Mgmt Group

• How do organisations operationalise NHI ownership at scale?
• When should organisations treat an NHI as a high-priority risk?
• How can organisations reduce the blast radius of compromised agent identities?
• Should organisations prioritise external exposure or internal credential governance first?